BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11172735)

  • 1. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro.
    Sinha R; Unni E; Ganther HE; Medina D
    Biochem Pharmacol; 2001 Feb; 61(3):311-7. PubMed ID: 11172735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.
    Jiang C; Ganther H; Lu J
    Mol Carcinog; 2000 Dec; 29(4):236-50. PubMed ID: 11170262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro growth inhibition of mouse mammary epithelial tumor cells by methylseleninic acid: involvement of protein kinases.
    Singh U; Null K; Sinha R
    Mol Nutr Food Res; 2008 Nov; 52(11):1281-8. PubMed ID: 18686292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
    Ip C; Thompson HJ; Zhu Z; Ganther HE
    Cancer Res; 2000 Jun; 60(11):2882-6. PubMed ID: 10850432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
    Wang Z; Jiang C; Ganther H; Lü J
    Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cell cycle arrest by methylseleninic acid.
    Zhu Z; Jiang W; Ganther HE; Thompson HJ
    Cancer Res; 2002 Jan; 62(1):156-64. PubMed ID: 11782373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
    Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
    Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.
    Unni E; Kittrell FS; Singh U; Sinha R
    Breast Cancer Res; 2004; 6(5):R586-92. PubMed ID: 15318939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
    Park JM; Kim A; Oh JH; Chung AS
    Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol.
    Wang Z; Jiang C; Lü J
    Mol Carcinog; 2002 Jul; 34(3):113-20. PubMed ID: 12112305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of organic and inorganic selenium compounds on rat mammary tumor cells.
    Ronai Z; Tillotson JK; Traganos F; Darzynkiewicz Z; Conaway CC; Upadhyaya P; el-Bayoumy K
    Int J Cancer; 1995 Nov; 63(3):428-34. PubMed ID: 7591244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice.
    Zeng H; Wu M
    Nutr Cancer; 2015; 67(5):831-8. PubMed ID: 26011019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.
    Unni E; Koul D; Yung WK; Sinha R
    Breast Cancer Res; 2005; 7(5):R699-707. PubMed ID: 16168115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.
    Li GX; Lee HJ; Wang Z; Hu H; Liao JD; Watts JC; Combs GF; Lü J
    Carcinogenesis; 2008 May; 29(5):1005-12. PubMed ID: 18310093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
    Hu H; Jiang C; Li G; Lü J
    Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
    Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
    Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells.
    Sinha R; Medina D
    Carcinogenesis; 1997 Aug; 18(8):1541-7. PubMed ID: 9276628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization.
    Leonard KA; Hall JP; Nelen MI; Davies SR; Gollnick SO; Camacho S; Oseroff AR; Gibson SL; Hilf R; Detty MR
    J Med Chem; 2000 Nov; 43(23):4488-98. PubMed ID: 11087573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention.
    Lu J; Pei H; Ip C; Lisk DJ; Ganther H; Thompson HJ
    Carcinogenesis; 1996 Sep; 17(9):1903-7. PubMed ID: 8824512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.
    Sinha I; Null K; Wolter W; Suckow MA; King T; Pinto JT; Sinha R
    Int J Cancer; 2012 Mar; 130(6):1430-9. PubMed ID: 21500193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.